Advertisement

Management of Trigeminal Neuralgia During Pregnancy

  • Bhanu Pratap Swain
Chapter

Abstract

Trigeminal neuralgia (TGN) is a debilitating painful condition which may manifest in pregnant females. It is a medical challenge for pain physicians in view of the limited therapeutic options during pregnancy and lack of adequate knowledge of this unique situation. Utility of the commonly used anti-epileptic drugs (AEDs) is questionable due the risk of teratogenic effect on fetus. Furthermore, there are not enough evidences regarding the safety of interventional procedures employed for TGN during pregnancy. When such a scenario is encountered, the management needs to be modified considering its implications on both mother and fetus.

References

  1. 1.
    Swain BP, Vidhya S, Jadon A, Chandra KN, Kumar S. Trigeminal neuralgia in pregnancy: a management challenge. Pain Pract. 2018;18:368–73.CrossRefGoogle Scholar
  2. 2.
    FDA pregnancy risk information: an update. Available from: https://www.drugs.com/pregnancy-categories.html.
  3. 3.
    Australian Department of Health. Therapeutic Goods Administration. Prescribing medicines in pregnancy database. Available from: http://www.tga.gov.au/hp/medicines-pregnancy.htm. Accessed Apr 24, 2018.
  4. 4.
    Vajda FJE, O’Brien TJ, Graham J, Lander CM, Eadie MJ. Is carbamazepine a human teratogen? J Clin Neurosci. 2015;23:34–7.CrossRefGoogle Scholar
  5. 5.
    Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin. 2005;21:693–701.CrossRefGoogle Scholar
  6. 6.
    Shaikh S, Yaacob HB, Abd Rahman RB. Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine. J Chin Med Assoc. 2011;74:243–9.CrossRefGoogle Scholar
  7. 7.
    Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15:240–4.CrossRefGoogle Scholar
  8. 8.
    Dolk H, Wang H, Loane M, Morris J, Garne E, Addor MC, et al. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology. 2016;86:1716–25.CrossRefGoogle Scholar
  9. 9.
    Wise J. Study finds lamotrigine to be safe during pregnancy. BMJ. 2017;359:j4827.CrossRefGoogle Scholar
  10. 10.
    Parmar BS, Shah KH, Gandhi IC. Baclofen in trigeminal neuralgia—a clinical trial. Indian J Dent Res. 1989:109–13.Google Scholar
  11. 11.
    Dalton CM, Keenan E, Jarrett L, Buckley L, Stevenson VL. The safety of baclofen in pregnancy: intrathecal therapy in multiple sclerosis. Mult Scler. 2008;14:571–2.CrossRefGoogle Scholar
  12. 12.
    Freeman EH, Delaney RM. Neonatal baclofen withdrawal: a case report of an infant presenting with severe feeding difficulties. J Pediatr Nurs. 2016;31:346–9.CrossRefGoogle Scholar
  13. 13.
    Baclofen and pregnancy: birth defects and withdrawal symptoms. Prescrire Int. 2015; 24:214.Google Scholar
  14. 14.
    Fujii H, Goel A, Bernard N, et al. Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study. Neurology. 2013;80:1565–70.CrossRefGoogle Scholar
  15. 15.
    Hill DS, Wlodarczyk BJ, Palacios AM, Finnell RH. Teratogenic effects of antiepileptic drugs. Expert Rev Neurother. 2010;10:943–59.CrossRefGoogle Scholar
  16. 16.
    Margulis AV, Mitchell AA, Gilboa SM, Werler MM, Mittleman MA, Glynn RJ, Hernandez-Diaz S, National Birth Defects Prevention Study. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol. 2012;207:405.e1–7.CrossRefGoogle Scholar
  17. 17.
    Koubeissi M. Levetiracetam: more evidence of safety in pregnancy. Epilepsy Currents. 2013;13:279–81.CrossRefGoogle Scholar
  18. 18.
    Morra ME, Elgebaly A, Elmaraezy A, Khalil AM, Altibi AM, Vu TL, et al. Therapeutic efficacy and safety of Botulinum Toxin A therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2016;17:63.CrossRefGoogle Scholar
  19. 19.
    Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo controlled trial. Cephalalgia. 2012;32:443–50.CrossRefGoogle Scholar
  20. 20.
    Morgan JC, Iyer SS, Moser ET, Singer C, Sethi KD. Botulinum toxin A during pregnancy: a survey of treating physicians. J Neurol Neurosurg Psychiatry. 2006;77:117–9.CrossRefGoogle Scholar
  21. 21.
    Gilbert-Barness E. Teratogenic causes of malformations. Ann Clin Lab Sci Spring. 2010;40:99–114.Google Scholar
  22. 22.
    Al-Quliti KW. Update on neuropathic pain treatment for trigeminal neuralgia: the pharmacological and surgical options. Neurosciences. 2015;20:107–14.CrossRefGoogle Scholar
  23. 23.
    Pollock BE. Surgical management of medically refractory trigeminal neuralgia. Curr Neurol Neurosci Rep. 2012;12:125–31.CrossRefGoogle Scholar
  24. 24.
    Lopez BC, Hamlyn PJ, Zakrzewska JM. Systematic review of ablative neurosurgical techniques for the treatment of trigeminal neuralgia. Neurosurgery. 2004;54:973–82.CrossRefGoogle Scholar
  25. 25.
    American College of Radiology. ACR-SPR practice parameter for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation. Available from: http://www.acr.org/media/ACR/Documents/PGTS/guidelines/Pregnant_Patients.pdf.
  26. 26.
    Shaw P, Duncan A, Vouyouka A, Ozsvath K. Radiation exposure and pregnancy. J Vasc Surg. 2011;53:28S–34S.CrossRefGoogle Scholar
  27. 27.
    Berman JM, Puscheck EE, Diamond MP. Full term vaginal live birth after laparoscopic radiofrequency ablation of a large, symptomatic intramural fibroid: A case report. J Reprod Med. 2012;57:159–63.PubMedGoogle Scholar
  28. 28.
    Kanjwal Y, Kosinski D, Kani M, Thomas W, Grubb B. Successful radiofrequency catheter ablation of left lateral accessory pathway using transseptal approach during pregnancy. J Interv Card Electrophysiol. 2005;13:239–42.CrossRefGoogle Scholar
  29. 29.
    Peters G, Nurmikko TJ. Peripheral and gasserian ganglion-level procedures for the treatment of trigeminal neuralgia. Clin J Pain. 2002;18:28–34.CrossRefGoogle Scholar
  30. 30.
    Kumar N, Shashni S, Singh R, Jain A. Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia. 2012;67:77–8.CrossRefGoogle Scholar
  31. 31.
    Nader A, Schittek H, Kendall MC. Lateral pterygoid muscle and maxillary artery are key anatomical landmarks for ultrasound-guided trigeminal nerve block. Anesthesiology. 2013;118:957.CrossRefGoogle Scholar
  32. 32.
    Gorgulho AA, De Salles AA. Impact of radiosurgery on the surgical treatment of trigeminal neuralgia. Surg Neurol. 2006;66:350–6.CrossRefGoogle Scholar
  33. 33.
    Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for the treatment of trigeminal neuralgia. Clin J Pain. 2002;18:42–7.CrossRefGoogle Scholar
  34. 34.
    Yu C, Jozsef G, Apuzzo ML, MacPherson DM, Petrovich Z. Fetal radiation doses for model C gamma knife radiosurgery. Neurosurgery. 2003;52:687–93.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Bhanu Pratap Swain
    • 1
  1. 1.Department of Anesthesiology and Critical CareTata Main HospitalJamshedpurIndia

Personalised recommendations